{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:06:20Z","timestamp":1791187580851,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":3531,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"onspecific Innate Immune Laboratory educational"},{"name":"Monash University, Melbourne Australia"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1111\/ajt.12165","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T16:26:34Z","timestamp":1361377594000},"page":"943-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Toll-Like Receptor 3 and 7\/8 Function Is Impaired in Hepatitis C Rapid Fibrosis Progression Post-Liver Transplantation"],"prefix":"10.1016","volume":"13","author":[{"given":"J.","family":"Howell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sawhney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Visvanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1111\/ajt.12165_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2004-832932","article-title":"Natural history and management of hepatitis C infection after liver transplantation","volume":"24","author":"Charlton","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1111\/ajt.12165_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2005.01.011","article-title":"What determines the natural history of recurrent hepatitis C after liver transplantation?","volume":"42","author":"Berenguer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12165_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12165_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: Update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12165_bib5","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1053\/j.gastro.2006.01.038","article-title":"Toll-like receptor signaling in the liver","volume":"130","author":"Schwabe","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12165_bib6","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.4049\/jimmunol.170.11.5615","article-title":"Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation","volume":"170","author":"Dolganiuc","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/ajt.12165_bib7","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.4049\/jimmunol.177.10.6758","article-title":"Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection","volume":"177","author":"Dolganiuc","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/ajt.12165_bib8","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","article-title":"Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6","volume":"80","author":"Machida","year":"2006","journal-title":"J Virol"},{"key":"10.1111\/ajt.12165_bib9","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4130::AID-IMMU4130>3.0.CO;2-W","article-title":"The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin","volume":"28","author":"Bopst","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1111\/ajt.12165_bib10","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ajt.12165_bib11","doi-asserted-by":"crossref","first-page":"8953","DOI":"10.1128\/JVI.00649-07","article-title":"Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines","volume":"81","author":"Abe","year":"2007","journal-title":"J Virol"},{"key":"10.1111\/ajt.12165_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/lt.20708","article-title":"Natural killer cells: Primary target for hepatitis C virus immune evasion strategies?","volume":"12","author":"Golden-Mason","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12165_bib13","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1111\/ajt.12165_bib14","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.175.3.1636","article-title":"TLR7\/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production","volume":"175","author":"Hart","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/ajt.12165_bib15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jhep.2005.12.025","article-title":"Anti-fibrotic activity of NK cells in experimental liver injury through killing of activated HSC","volume":"45","author":"Melhem","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12165_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/ajt.12165_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gut.51.2.248","article-title":"Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C","volume":"51","author":"Wali","year":"2002","journal-title":"Gut"},{"key":"10.1111\/ajt.12165_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4049\/jimmunol.174.2.727","article-title":"The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions","volume":"174","author":"Gerosa","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/ajt.12165_bib19","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/JVI.75.13.6209-6211.2001","article-title":"Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy","volume":"75","author":"Polyak","year":"2001","journal-title":"J Virol"},{"key":"10.1111\/ajt.12165_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2893.2007.00904.x","article-title":"Defective response to toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection","volume":"15","author":"Villacres","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1111\/ajt.12165_bib21","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.hep.2003.09.021","article-title":"Resolving the role of IL-6 in liver regeneration","volume":"38","author":"Zimmers","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12165_bib22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2004.11.043","article-title":"Interleukin-6 protects hepatocytes from CCl4-mediated necrosis and apoptosis in mice by reducing MMP-2 expression","volume":"42","author":"Bansal","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12165_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/11360","article-title":"Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon","volume":"5","author":"Cella","year":"1999","journal-title":"Nat Med"},{"key":"10.1111\/ajt.12165_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/cimm.1998.1406","article-title":"Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod","volume":"191","author":"Wagner","year":"1999","journal-title":"Cell Immunol"},{"key":"10.1111\/ajt.12165_bib25","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.4049\/jimmunol.178.7.4436","article-title":"TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection","volume":"178","author":"Yonkers","year":"2007","journal-title":"J Immunol"},{"key":"10.1111\/ajt.12165_bib26","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.0631696100","article-title":"Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7","volume":"100","author":"Lee","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ajt.12165_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jhep.2007.03.021","article-title":"A toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection","volume":"47","author":"Schott","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12165_bib28","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood-2010-04-281675","article-title":"Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education","volume":"116","author":"Bjorkstrom","year":"2010","journal-title":"Blood"},{"key":"10.1111\/ajt.12165_bib29","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1111\/ajt.12165_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbrc.2010.02.008","article-title":"Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment","volume":"393","author":"Dessouki","year":"2010","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1111\/ajt.12165_bib31","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1189\/jlb.0604372","article-title":"Natural killer cells inhibit hepatitis C virus expression","volume":"76","author":"Li","year":"2004","journal-title":"J Leukocyte Biol"},{"key":"10.1111\/ajt.12165_bib32","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s005350170057","article-title":"Th1\/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection","volume":"36","author":"Sobue","year":"2001","journal-title":"J Gastroenterol"},{"key":"10.1111\/ajt.12165_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/lt.21369","article-title":"Mission poorly accomplished: The protective role of natural killer cells in recurrent hepatitis C after liver transplantation","volume":"14","author":"Zein","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12165_bib34","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/gut.45.3.427","article-title":"Longitudinal variation in hepatitis C virus (HCV) viraemia and early course of HCV infection after liver transplantation for HCV cirrhosis: The role of different immunosuppressive regimens","volume":"45","author":"Papatheodoridis","year":"1999","journal-title":"Gut"},{"key":"10.1111\/ajt.12165_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/ajt.12165_bib36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/j.gastro.2003.11.018","article-title":"Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells","volume":"126","author":"Bataller","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/ajt.12165_bib37","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2005.076463","article-title":"Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C","volume":"55","author":"Nattermann","year":"2006","journal-title":"Gut"},{"key":"10.1111\/ajt.12165_bib38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/hep.510300144","article-title":"Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells","volume":"30","author":"Saile","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12165_bib39","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/jlts.2001.29414","article-title":"Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation","volume":"7","author":"Nelson","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12165_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.12165_bib41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.1082604","article-title":"Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease","volume":"300","author":"Foy","year":"2003","journal-title":"Science"},{"key":"10.1111\/ajt.12165_bib42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/hep.20666","article-title":"Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses","volume":"41","author":"Otsuka","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12165_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.23256","article-title":"Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells","volume":"51","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12165_bib44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/jhep.2002.33993","article-title":"Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients","volume":"36","author":"Berenguer","year":"2002","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12165_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: Increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"J Hepatol"},{"key":"10.1111\/ajt.12165_bib46","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.tp.0000279003.40279.0e","article-title":"Diabetes and hepatic oxidative damage are associated with hepatitis C progression after liver transplantation","volume":"84","author":"Cotler","year":"2007","journal-title":"Transplantation"},{"key":"10.1111\/ajt.12165_bib47","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/lt.21598","article-title":"The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age","volume":"14","author":"Selzner","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12165_bib48","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/lt.21626","article-title":"Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome\u2014comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis","volume":"15","author":"Aguilera","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12165_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/lt.21312","article-title":"Recurrent hepatitis C after liver transplantation: On-treatment prediction of response to peginterferon\/ribavirin therapy","volume":"14","author":"Hanouneh","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12165_bib50","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/lt.20238","article-title":"One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection","volume":"10","author":"Firpi","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1111\/ajt.12165_bib51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.510290122","article-title":"High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes","volume":"29","author":"Prieto","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/ajt.12165_bib52","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.21090","article-title":"Hepatic venous pressure gradient identified patients at risk of severe hepatitis C recurrence after liver transplantation","volume":"43","author":"Blasco","year":"2006","journal-title":"Hepatology"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12165","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.12165","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522258985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522258985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.12165\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:00:16Z","timestamp":1761627616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522258985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S1600613522258985"],"URL":"https:\/\/doi.org\/10.1111\/ajt.12165","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-Like Receptor 3 and 7\/8 Function Is Impaired in Hepatitis C Rapid Fibrosis Progression Post-Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.12165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}